Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Aaron

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Busulfan therapy of central nervous system xenografts in athymic miceR H Aaron, G B Elion, O M Colvin, et al.
Biomaterials|March 1, 2012
Mussel-inspired silver-releasing antibacterial hydrogelsDominic E Fullenkamp, José G Rivera, Yong-Kuan Gong, et al.
Hawai'I Journal of Health & Social Welfare|August 12, 2024
<i>Nā Kānaka Maoli ma nā 'Āina 'Ē</i>: Exploring Place of Residency as a Native Hawaiian Health Predictor During the COVID-19 PandemicDayton K Seto-Myers, Reya H Mokiao, Santino G Camacho, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2006
Flexible phenylalanine-glycine nucleoporins as entropic barriers to nucleocytoplasmic transportRoderick Y H Lim, Ning-Ping Huang, Joachim Köser, et al.
Frontiers in Artificial Intelligence|November 18, 2024
Enhancing random forest predictive performance for foot and mouth disease outbreaks in Uganda: a calibrated uncertainty prediction approach for varying distributionsGeofrey Kapalaga, Florence N Kivunike, Susan Kerfua, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2020
Preclinical Characterization of HPN536, a Trispecific, T-Cell-Activating Protein Construct for the Treatment of Mesothelin-Expressing Solid TumorsMary Ellen Molloy, Richard J Austin, Bryan D Lemon, et al.
Molecular Cancer Therapeutics|November 18, 2020
TriTACs, a Novel Class of T-Cell-Engaging Protein Constructs Designed for the Treatment of Solid TumorsRichard J Austin, Bryan D Lemon, Wade H Aaron, et al.
Molecular Cancer Therapeutics|April 26, 2024
HPN328, a Trispecific T Cell-Activating Protein Construct Targeting DLL3-Expressing Solid TumorsMary E Molloy, Wade H Aaron, Manasi Barath, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Busulfan therapy of central nervous system xenografts in athymic miceR H Aaron, G B Elion, O M Colvin, et al.
Biomaterials|March 1, 2012
Mussel-inspired silver-releasing antibacterial hydrogelsDominic E Fullenkamp, José G Rivera, Yong-Kuan Gong, et al.
Hawai'I Journal of Health & Social Welfare|August 12, 2024
<i>Nā Kānaka Maoli ma nā 'Āina 'Ē</i>: Exploring Place of Residency as a Native Hawaiian Health Predictor During the COVID-19 PandemicDayton K Seto-Myers, Reya H Mokiao, Santino G Camacho, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2006
Flexible phenylalanine-glycine nucleoporins as entropic barriers to nucleocytoplasmic transportRoderick Y H Lim, Ning-Ping Huang, Joachim Köser, et al.
Frontiers in Artificial Intelligence|November 18, 2024
Enhancing random forest predictive performance for foot and mouth disease outbreaks in Uganda: a calibrated uncertainty prediction approach for varying distributionsGeofrey Kapalaga, Florence N Kivunike, Susan Kerfua, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2020
Preclinical Characterization of HPN536, a Trispecific, T-Cell-Activating Protein Construct for the Treatment of Mesothelin-Expressing Solid TumorsMary Ellen Molloy, Richard J Austin, Bryan D Lemon, et al.
Molecular Cancer Therapeutics|November 18, 2020
TriTACs, a Novel Class of T-Cell-Engaging Protein Constructs Designed for the Treatment of Solid TumorsRichard J Austin, Bryan D Lemon, Wade H Aaron, et al.
Molecular Cancer Therapeutics|April 26, 2024
HPN328, a Trispecific T Cell-Activating Protein Construct Targeting DLL3-Expressing Solid TumorsMary E Molloy, Wade H Aaron, Manasi Barath, et al.
Pageof 5